View Author
screening cancer colorectal colorectal cancer study colonoscopy level gfobt subject fs screening colorectal cancer screening preference screenee blood result occult trial individual interval faecal crc screening health population patient sigmoidoscopy value adenomas choice detection programme uptake mortality screening test reduction risk reduction participant immunochemical polyps strategy detection rate participation group netherland table adenoma characteristic screening interval difference randomised chapter women screening programme screening tests number sample round crc screening programme sensitivity gastroenterology preparation model questionnaire analysis pathologist burden occult blood test surveillance testing respondent method endoscopy participation rate insulin sensitivity gfobt screening van leerdam agreement effect van ballegooijen m van vuuren aj target population
10 Most Recent Publications
|
What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
(Article)
Dam, L. van Korfage, I.J. Kuipers, E.J. Hol, L. Roon, A.H.C. van Reijerink, J.C.I.Y. Ballegooijen, M. van Leerdam, M.E. van |
2013-04-08
|
|
Are fecal immunochemical test characteristics influenced by sample return time a population-based colorectal cancer screening trial
(Article)
Roon, A.H.C. van Hol, L. Kuipers, E.J. Leerdam, M.E. van Vuuren, A.J. van Francke, J. Ouwendijk, M. Heijens, A. Nagtzaam, N.M. Reijerink, J.C.I.Y. Togt, A.C.M. van der Ballegooijen, M. van |
2012-01-01
|
|
Fecal occult blood testing when colonoscopy capacity is limited
(Article)
Wilschut, J.A. Habbema, J.D.F. Leerdam, M.E. van Hol, L. Lansdorp-Vogelaar, I. Kuipers, E.J. Ballegooijen, M. van |
2011-12-07
|
|
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
(Article)
Wilschut, J.A. Hol, L. Dekker, E. Jansen, J.B. Leerdam, M.E. van Lansdorp-Vogelaar, I. Kuipers, E.J. Habbema, J.D.F. Ballegooijen, M. van |
2011-11-01
|
|
Advance notification letters increase adherence in colorectal cancer screening: A population-based randomized trial
(Article)
Roon, A.H.C. van Hol, L. Wilschut, J.A. Reijerink, J.C.I.Y. Vuuren, A.J. van Ballegooijen, M. van Habbema, J.D.F. Leerdam, M.E. van Kuipers, E.J. |
2011-06-01
|
|
Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screening
(Article)
Putten, P. van Hol, L. Dekken, H. van Krieken, J.H.J.M. van Ballegooijen, M. van Kuipers, E.J. Leerdam, M.E. van |
2011-05-01
|
|
Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screening
(Article)
Putten, P. van Hol, L. Dekken, H. van Krieken, J.H.J.M. van Ballegooijen, M. van Kuipers, E.J. Leerdam, M.E. van |
2011-05-01
|
|
Diagnostic Yield Improves With Collection of 2 Samples in Fecal Immunochemical Test Screening Without Affecting Attendance
(Article)
Roon, A.H.C. van Wilschut, J.A. Togt, A.C.M. van der Habbema, J.D.F. Leerdam, M.E. van Kuipers, E.J. Hol, L. Ballegooijen, M. van Reijerink, J.C.I.Y. 't Mannetje, H. Kranenburg, L.J.C. Biermann, K. Vuuren, A.J. van Francke, J. |
2011-04-01
|
|
Uptake of faecal immunochemical test screening among non-participants in a flexible sigmoidoscopy screening programme
(Article)
Ballegooijen, M. van Hol, L. Vuuren, A.J. van Kuipers, E.J. Habbema, J.D.F. Reijerink, J.C.I.Y. Leerdam, M.E. van |
2011-01-01
|
|
Screening for colorectal cancer: Comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy
(Article)
Hol, L. Jonge, V. de Leerdam, M.E. van Ballegooijen, M. van Looman, C.W.N. Vuuren, A.J. van Reijerink, J.C.I.Y. Habbema, J.D.F. Essink-Bot, M.L.E. Kuipers, E.J. |
2010-07-01
|
